The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy." 

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

After an official request from Edwards Lifesciences, CMS is rethinking its coverage policy for the use of TAVR to treat asymptomatic severe aortic stenosis. The agency is accepting public comments on this topic until Jan. 14. 

Perhaps the biggest sticking point in the debate around remote imaging operations relates to the bedside. If a technologist is running the exam remotely, who is tending to patients on-site? 

Lauren Beene, MD, and Valerie Fouts-Fowler, MD, allege in a lawsuit that Ohio-based University Hospitals fired them for expressing concerns through a chat app. The health system accused the duo of misusing internal communications for personal gain. 

The director of the National Institutes of Health and his principal deputy are touting their success at ‘curing’ the agency of its self-inflicted DEI disability. 

Three out of four TTEs are being ordered by clinicians who are not cardiologists. Could this be having a negative impact on patient care?

Yale New Haven failed to notify parents about the use of the cow-based formula, which they expressly asked staff not to use. A judge found that the hospital failed to stock a human alternative, known to be safer for premature newborns.